CTT PHARMACEUTICAL HOLDINGS, INC. Operating Income Loss

Quick Answer

CTT PHARMACEUTICAL HOLDINGS, INC. reported Operating Income Loss of $92.2 thousand for the year ending 2013.

  • CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +107.7% in Operating Income Loss from 2012 to 2013.
  • This data is from CTT PHARMACEUTICAL HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 10, 2014.
  • XBRL data for this metric is available from 2010 to 2013 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2010 to 2013), CTT PHARMACEUTICAL HOLDINGS, INC.'s Operating Income Loss has grown by 104.5%.
  • Historical annual values: Fiscal year 2013: $92.2 thousand | Fiscal year 2012: -$1.19 million | Fiscal year 2011: -$757.9 thousand | Fiscal year 2010: -$2.07 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: